Health Canada Approves Otsuka and Lundbeck’s (Pr)ABILIFY ASIMTUFII® (aripiprazole), the First-and-Only, Once-Every-Two-Months, Long-Acting Injectable (LAI) Treatment for Schizophrenia and for Maintenance Monotherapy of Bipolar I Disorder in Adults

Medications
1

Thus might be of interest to @Patrick

5 Likes
2

My Psychiatrist gave me a heads up that this was coming. I’d go for a once every two month injection. Right now I’m monthly.

Thanks for sharing @everhopeful

1 Like